ENT Endoscopy Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the ENT endoscopy devices market size is projected to expand from USD 5.96 billion in 2025 and USD 6.36 billion in 2026 to USD 8.82 billion by 2031, registering a CAGR of 6.75% between 2026 to 2031.

Global ENT Endoscopy Devices Market Trends and Insights

Rising Burden of Chronic Sinusitis and Upper-Airway Disorders

Chronic rhinosinusitis remains a major source of procedure volume for the ENT endoscopy devices market. Nasal inflammation associated with pollution exposure and allergen sensitization can sustain care needs outside infectious disease pathways, particularly where recurring symptoms require clinical monitoring, imaging, follow-up, and specialist review. This reduces the scope for pharmaceutical treatment alone to replace endoscopic assessment or surgery. Functional endoscopic sinus surgery is used when symptoms remain unresolved after medical management and when clinical evaluation supports intervention. A 10-year NHS analysis found a positive correlation of R = 0.74 between rhinology procedure volume and time. This relationship supports continuing demand for sinus endoscopes as clinical activity rises in the ENT endoscopy devices market.

Shift Toward Minimally Invasive and Office-Based ENT Procedures

Minimally invasive care is moving more ENT assessment and treatment into settings outside the main operating room. Office-based examinations need equipment that can be prepared quickly, used in smaller clinical rooms, and managed without extensive support infrastructure. Flexible rhinolaryngoscopes and portable video systems are well-suited to this setting. The purchasing decision increasingly considers setup time, service requirements, and the need for reprocessing support. Smaller practices may therefore prefer systems with fewer supporting components. This care model expands the range of potential buyers for the ENT endoscopy devices market and supports demand in community-based care.

High Capital Cost and Lifecycle Maintenance Requirements

Advanced ENT endoscopy systems require spending beyond the initial device purchase. Premium 4K rigid scope towers also need service, repair, calibration, software support, and replacement support through their working lives. Large academic hospitals can absorb these costs through bundled agreements, centralized technical teams, and established purchasing processes. Smaller clinics may defer replacement when repair costs become difficult to justify against other clinical spending priorities. The issue is more pronounced in emerging APAC and South American markets where authorized service coverage for imported equipment can be limited, leading to longer downtime and delayed upgrades. This creates uneven adoption of premium platforms even when clinical demand is present in the ENT endoscopy devices market.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of High-Definition and Digital Visualization
2. Growth of Ambulatory Surgical Centers and Outpatient ENT Care
3. Reprocessing, Sterilization, and Cross-Contamination Risk

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Rigid endoscopes held 50.31% of revenue in 2025. Their position reflects the continuing importance of functional endoscopic sinus surgery and endoscopic ear surgery in hospitals and established surgical centers. Rod-lens sinus telescopes and otology telescopes provide the optical clarity, stability, and working distance that these procedures require. Hospitals have also installed infrastructure for rigid scopes, camera heads, light sources, and supporting imaging equipment, which makes replacement purchases more practical than changing platforms. The 10-year NHS analysis reported a positive R = 0.74 relationship between rhinology procedure volume and time, supporting recurring procurement of rigid sinus scopes as clinical activity rises.

Flexible endoscopes are projected to grow at a CAGR of 8.58% through 2031. Their adoption is strongest in office-based rhinology diagnostics, airway assessment, follow-up examinations, and other workflows that need a maneuverable scope. Olympus launched ENDOEYE ULTRA in June 2026 with 4K and infrared observation capabilities in one flexible-tip videoscope. This reduces the historic choice between flexible access and high-quality visualization, while allowing clinicians to use a single device format in more procedures. Flexible rhinolaryngoscopes and nasopharyngoscopes serve high-volume diagnostic workflows outside surgical settings, while fiberoptic products remain relevant in cost-sensitive applications, and integrated video systems support premium outpatient workflows.

Reusable devices accounted for 76.24% of revenue in 2025. Their position reflects years of hospital investment in capital equipment, central sterile services, and trained staff for reprocessing. Reusable rod-lens systems can offer favorable amortized economics where procedure volumes are sufficient to spread equipment and service costs across many cases. Their installed base also supports continuing purchases of repair services, maintenance contracts, accessories, and replacement components. This gives reusable equipment a durable role in the ENT endoscopy devices market, especially at hospitals that already manage the full operating workflow.

Single-use devices are projected to grow at a CAGR of 9.22% through 2031. Olympus introduced the Vathin E-SteriScope single-use flexible video rhinolaryngoscope in select EMEA markets in October 2025. KARL STORZ introduced the Slimline C-MAC S single-use video laryngoscope in April 2025. These products respond to reprocessing labor, infection-control concerns, equipment availability, and the need to simplify clinical preparation in facilities with limited technical support. They also shift purchasing toward recurring unit orders rather than large capital agreements. At the same time, limited-use devices remain a middle option for office settings where reusable infrastructure is limited and fully disposable economics remain difficult.

Complete Report Scope:

• By Product Type
  • Rigid Endoscopes
    • Rod-Lens Endoscopes
    • Sinus Telescopes
    • Otology Telescopes
    • Laryngeal Telescopes
    • Pediatric and Small-Diameter Telescopes
  • Flexible Endoscopes
    • Flexible Rhino-Laryngoscopes
    • Flexible Nasopharyngoscopes
    • Flexible Laryngoscopes
    • Flexible Otoscopes
  • Video Endoscopes and Imaging Systems
    • Video Rhino-Laryngo Endoscopes
    • Video Laryngoscopes
    • Integrated ENT Camera Systems
    • Portable ENT Imaging Systems
  • Fiberoptic Endoscopes
  • Endoscopic Accessories and Consumables
• By Usability
  • Reusable Devices
  • Single-Use Devices
  • Limited-Use Devices
  • Others (Hybrid Reusable, Disposable Platforms, and More)
• By Application
  • Rhinology and Nasal Examination
  • Laryngology and Voice Disorders
  • Otology and Ear Disorders
  • Pediatric and Neonatal ENT
  • Airway Assessment and Swallowing Evaluation
  • Other Applications
• By End User
  • Hospitals and Academic Medical Centers
  • Ambulatory Surgical Centers
  • ENT Specialty Clinics
  • Office-Based ENT Practices
  • Diagnostic Imaging Centers
  • Other End Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 38.61% of global revenue in 2025. Mature reimbursement systems, specialist availability, and outpatient migration support regional demand for the ENT endoscopy devices market. The region has a large base of hospital and ambulatory purchasers that can adopt advanced imaging systems and maintain them through established service channels. Portable and single-use scopes can extend access beyond hospital procurement departments and into office-based care. The region also faces close scrutiny of reusable-device reprocessing and product safety, which supports demand for reliable visualization and practical infection-control workflows.

Europe remains an important manufacturing base for rigid ENT optics and related equipment. EU MDR 2017/745 increases clinical evidence and post-market surveillance requirements for medical devices, raising the importance of established regulatory processes and notified-body relationships. German manufacturers, including Richard Wolf and XION, have deep experience in rigid optics and specialized ENT products, which supports their position in this environment. The United Kingdom faces unmet demand for rhinology surgery following post-pandemic backlogs, which can support capital procurement over time. European buyers also place strong emphasis on product service, documentation, compliance, and the ability to support long product life cycles.

Asia-Pacific is projected to grow at a CAGR of 8.75% through 2031. China, India, Japan, South Korea, and Southeast Asia combine demographic demand with different levels of healthcare investment and equipment access. Research on China's aging population supports the need for continuing hearing-loss assessment and otology care. India offers scope for adoption through hospital modernization and expansion of ENT specialty centers in Tier 2 cities, while Japan retains a significant domestic equipment base. GCC investment and rising procedure volumes in Brazil and Argentina can build a longer-term purchaser base in MEA and South America, where portable and single-use platforms may offer an initial route into the ENT endoscopy devices market.

1. Aesculap
2. Ambu
3. ATMOS MedizinTechnik
4. B. Braun
5. Boston Scientific
6. Conmed
7. FUJIFILM
8. HOYA
9. Karl Storz
10. Medtronic
11. Olympus
12. Olympus Vathin
13. OPTIM
14. Pioneer Healthcare Technologies
15. Richard Wolf
16. Smiths Group
17. Stryker
18. XION GmbH

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support